These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 18660702

  • 1. Activation of the innate immune system by the endogenous ligand hyaluronan.
    Shirali AC, Goldstein DR.
    Curr Opin Organ Transplant; 2008 Feb; 13(1):20-5. PubMed ID: 18660702
    [Abstract] [Full Text] [Related]

  • 2. Innate alloimmunity: history and current knowledge.
    Land W.
    Exp Clin Transplant; 2007 Jun; 5(1):575-84. PubMed ID: 17617046
    [Abstract] [Full Text] [Related]

  • 3. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
    Goldstein DR, Palmer SM.
    J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
    [Abstract] [Full Text] [Related]

  • 4. Toll-like receptors and other links between innate and acquired alloimmunity.
    Goldstein DR.
    Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
    [Abstract] [Full Text] [Related]

  • 5. Roles of toll-like receptors signaling in organ transplantation.
    Li T, Chen G, Zhang Z.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
    [Abstract] [Full Text] [Related]

  • 6. Toll like receptors and acute allograft rejection.
    Goldstein DR.
    Transpl Immunol; 2006 Dec; 17(1):11-5. PubMed ID: 17157206
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of innate and adaptive immunity on rejection and tolerance.
    Kim IK, Bedi DS, Denecke C, Ge X, Tullius SG.
    Transplantation; 2008 Oct 15; 86(7):889-94. PubMed ID: 18852649
    [Abstract] [Full Text] [Related]

  • 9. Tracking the toll of kidney disease.
    Shirali AC, Goldstein DR.
    J Am Soc Nephrol; 2008 Aug 15; 19(8):1444-50. PubMed ID: 18579638
    [Abstract] [Full Text] [Related]

  • 10. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
    Land WG, Gutmann T, Daar AS.
    Acta Chir Belg; 2008 Aug 15; 108(1):73-82. PubMed ID: 18411578
    [Abstract] [Full Text] [Related]

  • 11. The role of Toll-like receptors in non-infectious lung injury.
    Jiang D, Liang J, Li Y, Noble PW.
    Cell Res; 2006 Aug 15; 16(8):693-701. PubMed ID: 16894359
    [Abstract] [Full Text] [Related]

  • 12. Toll-like receptors and graft rejection.
    Liu G, Wu Y, Gong S, Zhao Y.
    Transpl Immunol; 2006 Jun 15; 16(1):25-31. PubMed ID: 16701173
    [Abstract] [Full Text] [Related]

  • 13. Innate immunity-mediated allograft rejection and strategies to prevent it.
    Land WG.
    Transplant Proc; 2007 Apr 15; 39(3):667-72. PubMed ID: 17445569
    [Abstract] [Full Text] [Related]

  • 14. Innate immunity and its role in type 1 diabetes.
    Zipris D.
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug 15; 15(4):326-31. PubMed ID: 18594272
    [Abstract] [Full Text] [Related]

  • 15. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
    Wang Y, Abarbanell AM, Herrmann JL, Weil BR, Poynter J, Manukyan MC, Crisostomo PR, Meldrum DR.
    Shock; 2010 Dec 15; 34(6):548-57. PubMed ID: 20458266
    [Abstract] [Full Text] [Related]

  • 16. Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system.
    Fox-Marsh A, Harrison LC.
    J Leukoc Biol; 2002 Mar 15; 71(3):401-9. PubMed ID: 11867677
    [Abstract] [Full Text] [Related]

  • 17. Innate immunity in transplant tolerance and rejection.
    Murphy SP, Porrett PM, Turka LA.
    Immunol Rev; 2011 May 15; 241(1):39-48. PubMed ID: 21488888
    [Abstract] [Full Text] [Related]

  • 18. [Sterile inflammatory response to ischemia-reperfusion injury: immediate and long term consequences on graft function].
    Thaunat O.
    Bull Acad Natl Med; 2011 May 15; 195(4-5):847-59; discussion 859. PubMed ID: 22375356
    [Abstract] [Full Text] [Related]

  • 19. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer.
    Misra S, Hascall VC, Berger FG, Markwald RR, Ghatak S.
    Connect Tissue Res; 2008 May 15; 49(3):219-24. PubMed ID: 18661347
    [Abstract] [Full Text] [Related]

  • 20. CARD9 signaling in the innate immune response.
    Ruland J.
    Ann N Y Acad Sci; 2008 Nov 15; 1143():35-44. PubMed ID: 19076343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.